Category Archives: Regional News

You are here: Home » Category: "Regional News"

BioCryst's BCX7353 Receives European Regulatory Designations for the Treatment of Hereditary Angioedema

EMA Grants Orphan DesignationUK MHRA Grants Promising Innovative Medicine Designation RESEARCH TRIANGLE PARK, N.C., May 24, 2018 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, today announced that the European Medicines Agency’s (“EMA”) Committee for Orphan Medicinal Products (“COMP”) issued a positive…

[Read More]

U.S. FDA Grants Fast Track Designation for Krystal Biotech’s KB103 for the Treatment of Dystrophic Epidermolysis Bullosa

PITTSBURGH, May 24, 2018 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ:KRYS), a gene therapy company developing topical and intradermal “off-the-shelf” treatments for rare dermatological diseases, today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to KB103 for the treatment of dystrophic epidermolysis bullosa (DEB). KB103 is the first-ever…

[Read More]

Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D

PLYMOUTH MEETING, Pa., May 24, 2018 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that it has bolstered its efforts to attract partnerships and collaborations and increase non-dilutive funding with the hiring of an accomplished business development leader and the promotion of a key R&D leader. Mr. Shawn D. Bridy joins Inovio as Vice…

[Read More]

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine

OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 24, 2018 (GLOBE NEWSWIRE) — CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent BioSolutions Inc. (NYSE:EBS) under which Profectus and Emergent will receive up to $25 million to advance the development and manufacture of a vaccine against the Nipah virus (NiV),…

[Read More]

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (“BioCryst”) (NASDAQ:BCRX), and Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ:IDRA), today announced that they will be presenting at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 8:30 A.M. E.T.  Links to a live audio webcast and replay…

[Read More]

BioDelivery Sciences to Present at the Jefferies 2018 Global Healthcare Conference

RALEIGH, N.C., May 23, 2018 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that Herm Cukier, Chief Executive Officer, and Scott Plesha, President will present at the Jefferies 2018 Global Healthcare Conference taking place at the Grand Hyatt in New…

[Read More]

Florida Hospital Waterman offers new non-invasive treatment option for prostate cancer

CHARLOTTE, N.C., May 22, 2018 (GLOBE NEWSWIRE) — Florida Hospital Waterman now offers HIFU, High Intensity Focused Ultrasound, for prostate cancer available for men with localized prostate cancer. HIFU is a non-invasive treatment for prostate cancer that uses ultrasound energy to destroy prostatic tissue without a single incision and no blood loss. The HIFU treatment…

[Read More]